Compound for treating oxidative stress in mammals
AssigneeHemopet
InventorWinifred Jean Dodds
Life of this patent
Estimating the term…
Abstract
Managing and treating elevated OS biomarkers in mammals such as companion animals with at least one of the supplements alpha-lipoic acid, carnitine, co-enzyme Q-10, ginger, green tea, licorice, milk thistle, garlic, honey. resveratrol, soybeans, tomatoes, turmeric, vitamin D, vitamin E or selenium. Diagnosing an oxidative stress (OS) in a mammal comprises collecting a sample; screening the sample to detect the presence of an OS biomarker, selectively isoprostane and other antioxidants such as HODE microRNAs. TAC: GSH, MDA, and TNF-alpha. The sample can be saliva.
Claims22
A method of treating a dog with a diagnosed level above 1.75 ng/ml of the OS isoprostane biomarker comprising:
- a. formulating a composition to be a combination of at least vitamin D and selenium, alpha-lipoic acid, co-enzyme Q-10, green tea, and turmeric ingredients,
- b. mixing the ingredients together to be for ingestion by the dog,
- c. treating the dog with a diagnosed level above 1.75 ng/ml of the OS isoprostane biomarker with the combination composition, and
- d. reducing the level below 1.75 ng/ml of the OS isoprostane biomarker in the dog so treated by the composition combination.
A method of treating a dog with a diagnosed level above 1.75 ng/ml of the OS isoprostane biomarker comprising:
- a. formulating a composition as a combination of at least Alpha-Lipoic acid in an amount between 50 mg and 100 mg;
- Co-Enzyme Q-10 in an amount between 5 mg and 20 mg;
- Green tea in an amount between 50 mg and 200 mg;
- Selenium in an amount between 5 mcg and 20 mcg;
- Turmeric (curcumin) in an amount between 20 mg and 300 mg;
- Vitamin D in an amount between 25 mcg and 150 mcg;
- and
- b. treating the dog with a diagnosed level above 1.75 ng/ml of the OS isoprostane biomarker with the combination composition to lower the level below 1.75 ng/ml wherein the OS isoprostane biomarker in the dog so treated by the composition combination is reduced.
A method of treating a dog with a diagnosed level above 1.75 ng/ml of the OS isoprostane biomarker comprising:
- a. formulating the composition as a combination at least Alpha-Lipoic acid in an amount of about 20 mg;
- Co-Enzyme Q-10 in an amount of about 10 mg;
- Green tea in an amount of about 100 mg;
- Selenium in an amount of about 10 mcg;
- Turmeric (curcumin) in an amount of about 100 mg;
- Vitamin D in an amount of about 75 mcg;
- and
- b. treating the dog with a diagnosed level above 1.75 ng/ml of the OS isoprostane biomarker with the combination composition to lower the level below 1.75 ng/ml wherein the OS isoprostane biomarker in the dog so treated by the composition combination is reduced.
A method of treating a dog with a diagnosed level above 1.75 ng/ml of the OS isoprostane biomarker comprising:
- a. using a composition to reduce the isoprostane marker indicative of oxidative stress (OS) in a dog,
- b. formulating the composition as a combination consisting of vitamin D and selenium, alpha-lipoic acid, co-enzyme Q-10, green tea, and turmeric ingredients, and
- c. treating the dog with a level above 1.75 ng/ml of the OS isoprostane biomarker with the combination composition to lower the level below 1.75 ng/ml wherein the OS isoprostane biomarker in the dog so treated by the composition combination is reduced.
A method of treating a dog with a diagnosed level above 1.75 ng/ml of the OS isoprostane biomarker comprising:
- a. formulating a composition to consist of a combination of at least Alpha-Lipoic acid in an amount between 50 mg and 100 mg;
- Co-Enzyme Q-10 in an amount between 5 mg and 20 mg;
- Green tea in an amount between 50 mg and 200 mg;
- Selenium in an amount between 5 mcg and 20 mcg;
- Turmeric (curcumin) in an amount between 20 mg and 300 mg;
- and Vitamin D in an amount between 25 mcg and 150 mcg;
- b. mixing the ingredients together for ingestion by the dog, and
- c. treating the dog with a diagnosed level above 1.75 ng/ml of the OS isoprostane biomarker with the combination composition to lower the level below 1.75 ng/ml wherein the OS isoprostane biomarker in the dog so treated by the composition combination is reduced.
A method of treating a dog with a diagnosed level above 1.75 ng/ml of the OS isoprostane biomarker
- a. using a composition to reduce an isoprostane marker indicative of oxidative stress (OS) in a dog, the composition being a combination consisting of Alpha-Lipoic acid in an amount of about 20 mg;
- Co-Enzyme Q-10 in an amount of about 10 mg;
- Green tea in an amount of about 100 mg;
- Selenium in an amount of about 10 mcg;
- Turmeric (curcumin) in an amount of about 100 mg;
- and Vitamin D in an amount of about 75 mcg;
- b. mixing the ingredients together and being for ingestion by the dog, and
- c. treating the dog with a diagnosed level above 1.75 ng/ml of the OS isoprostane biomarker with the combination composition to lower the level below 1.75 ng/ml wherein the OS isoprostane biomarker in the dog so treated by the composition combination is reduced.
Dependencies are inferred from the claim text.